We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
BioMag Receives Second Patent on Its High Throughput Screening - Magnetic Testing Platform
News

BioMag Receives Second Patent on Its High Throughput Screening - Magnetic Testing Platform

BioMag Receives Second Patent on Its High Throughput Screening - Magnetic Testing Platform
News

BioMag Receives Second Patent on Its High Throughput Screening - Magnetic Testing Platform

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "BioMag Receives Second Patent on Its High Throughput Screening - Magnetic Testing Platform "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

BioMag Corp., through its wholly owned subsidiary Biospectrum Technologies Inc., has announced that it has received its second patent from the U.S. Patent office on its High Throughput Screening - Magnetic Testing Platform (HTS-MTP) that is designed to produce both qualitative (yes/no) and quantitative (viral load) results from a single test.

Clayton Hardman, president and CEO of BioMag Corp., stated, "In addition to the HTS-MTP patent that was received from the U.S. Patent office in July of 2003, we have just received our second patent, further establishing our technology and enabling a broad spectrum of applications in which our product applies, in both medical testing and diagnostics."

"It is safe to say that our product is one of a kind in which can potentially revolutionize the diagnostic industry."

Advertisement